Related Experiment Video
Updated: Mar 7, 2026

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration
Published on: February 23, 2019
Oncogenomic disruptions in arsenic-induced carcinogenesis
Adam P Sage1, Brenda C Minatel1, Kevin W Ng1
1Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Abstract:
Chronic exposure to arsenic affects more than 200 million people worldwide, and has been associated with many adverse health effects, including cancer in several organs. There is accumulating evidence that arsenic biotransformation, a step in the elimination of arsenic from the human body, can induce changes at a genetic and epigenetic level, leading to carcinogenesis. At the genetic level, arsenic interferes with key cellular processes such as DNA damage-repair and chromosomal structure, leading to genomic instability. At the epigenetic level, arsenic places a high demand on the cellular methyl pool, leading to global hypomethylation and hypermethylation of specific gene promoters. These arsenic-associated DNA alterations result in the deregulation of both oncogenic and tumour-suppressive genes. Furthermore, recent reports have implicated aberrant expression of non-coding RNAs and the consequential disruption of signaling pathways in the context of arsenic-induced carcinogenesis. This article provides an overview of the oncogenomic anomalies associated with arsenic exposure and conveys the importance of non-coding RNAs in the arsenic-induced carcinogenic process.
Insights
Chronic arsenic exposure causes cancer by altering DNA and gene regulation. Arsenic biotransformation impacts genetic and epigenetic processes, leading to oncogenomic anomalies and the disruption of non-coding RNAs.
Area of Science:
- Environmental Health
- Molecular Biology
- Cancer Research
Background:
- Chronic arsenic exposure affects over 200 million people globally.
- Arsenic exposure is linked to various cancers and adverse health outcomes.
- Arsenic biotransformation is implicated in arsenic-induced carcinogenesis.
Purpose of the Study:
- To provide an overview of oncogenomic anomalies associated with arsenic exposure.
- To highlight the role of non-coding RNAs in arsenic-induced carcinogenesis.
Main Methods:
- Review of existing literature on arsenic's effects on genetic and epigenetic levels.
- Analysis of how arsenic biotransformation influences DNA integrity and gene expression.
- Examination of the role of non-coding RNAs in arsenic-induced cancer.
Main Results:
- Arsenic exposure causes genetic alterations, including DNA damage-repair interference and genomic instability.
- Arsenic exposure leads to epigenetic changes, such as global hypomethylation and promoter-specific hypermethylation.
- Deregulation of oncogenic and tumor-suppressive genes occurs due to arsenic-associated DNA alterations.
- Aberrant non-coding RNA expression disrupts signaling pathways, contributing to arsenic-induced carcinogenesis.
Conclusions:
- Arsenic exposure induces significant oncogenomic anomalies.
- Non-coding RNAs play a critical role in the carcinogenic process initiated by arsenic exposure.
More Related Videos
Related Concept Videos
Mutagenicity and Carcinogenicity
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)